| Clinical determinants and mortality predictability of stearoyl-CoA desaturase-1 activity indices in dialysis patients. | |
| | |
MedLine Citation:
|
PMID: 22897446 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
BACKGROUND: Stearoyl-CoA desaturase-1 (SCD-1) converts dietary saturated fatty acids to monounsaturated fatty acids. Elevated SCD-1 activity thus signifiesimpaired fatty acid metabolism and excess saturated fat intake. In the general population,increased SCD-1 activity is associated with cardiovascular disease and mortality. The determinants and implications of SCD-1 activity in dialysis patients are unknown. SUBJECTS: A total of222 dialysis patients (39% women) with prospective follow-up, median age of 57 years and an average of 12 months of dialysis. DESIGN: Fatty acid compositions in plasma phospholipids and free fatty acids (FFAs) were assessed by gas-liquid chromatography. SCD-1 activity indices were calculated asthe product-to-precursor fatty acid ratio (palmitoleic acid/palmitic acid) in each fraction to reflect SCD-1 activities in the liver and adipose tissue. RESULTS: Median hepatic and adipose tissue SCD-1 activity indices were 0.016 and 0.150, respectively. In multivariate analyses, SCD-1 was positively associated with age, female sex and serum interleukin-6 level. During 18.4 (interquartile range5.5-37.3) months of follow-up, there were 61 deaths and 115 kidney transplants. The cut-off level for high SCD-1 indices was determined by receiver operating characteristic curve analyses. In fully adjusted competing risk models, patients with high SCD-1 indices in both phospholipids and FFAs had more than two-fold increased mortality risk before kidney transplantation [hazard ratio (HR)2.29, 95% confidence interval (CI) 1.28-4.11 and HR 2.36, 95% CI 1.38-4.03, respectively],compared with patients with low SCD-1 indices. CONCLUSIONS: Both hepatic and adipose tissue SCD-1 activity indices independently predict mortality in dialysis patients. Further studies are warranted to determine whether reducing SCD-1 activity by dietary intervention(limiting saturated fat) could improve survival in dialysis patients. © 2012 The Association for the Publication of the Journal of Internal Medicine. |
| | |
Authors:
|
Xiaoyan Huang; Peter Stenvinkel; Abdul Rashid Qureshi; Tommy Cederholm; Peter Bárány; Olof Heimbürger; Bengt Lindholm; Ulf Risérus; Juan Jesús Carrero |
Related Documents
:
|
3316396 - An indirect enzymoimmunological assay for hyaluronidase. 22687746 - A new facile synthetic route to [11c]gsk189254, a selective pet radioligand for imaging... 22723266 - Nesfatin-1 inhibits gastric acid secretion via a central vagal mechanism in rats. 2474276 - The effects of 4-pentenoic and pentanoic acids on the isolated rat atria. 4074196 - Effects of fenofibrate on bile lipid composition. 2674496 - Effects of short chain fatty acids on the production of heat-labile enterotoxin from en... |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-8-17 |
Journal Detail:
|
Title: Journal of internal medicine Volume: - ISSN: 1365-2796 ISO Abbreviation: J. Intern. Med. Publication Date: 2012 Aug |
Date Detail:
|
Created Date: 2012-8-17 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8904841 Medline TA: J Intern Med Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
© 2012 The Association for the Publication of the Journal of Internal Medicine. |
Affiliation:
|
Divisions of Renal Medicine and Baxter Novum, Department of Clinical Science, Intervention, and Technology, Karolinska Institutet, Stockholm. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Getting a handle on how the brain generates complexity.
Next Document: Treatment evaluation of liraglutide in type 2 diabetes.